Literature DB >> 21432299

Impact of intensive care unit-acquired infection on hospital mortality in Japan: A multicenter cohort study.

Machi Suka1, Katsumi Yoshida, Jun Takezawa.   

Abstract

OBJECTIVES: To elucidate factors associated with hospital mortality in intensive care unit (ICU) patients and to evaluate the impact of ICU-acquired infection on hospital mortality in the context of the drug resistance of pathogens.
METHODS: By using the Japanese Nosocomial Infection Surveillance (JANIS) database, 7,374 patients who were admitted to the 34 participating ICUs between July 2000 and May 2002, were aged 16 years or older, and who stayed in the ICU for 48 to 1,000 hours, did not transfer to another ICU, and did not become infected within 2 days after ICU admission, were followed up until hospital discharge or to Day 180 after ICU discharge. Adjusted hazard ratios (HRs) with the 95% confidence intervals (CIs) for hospital mortality were calculated using Cox's proportional hazard model.
RESULTS: After adjusting for sex, age, and severity-of-illness (APACHE II score), a significantly higher HR for hospital mortality was found in ventilator use, central venous catheter use, and ICU-acquired drug-resistant infection, with a significantly lower HR in elective or urgent operations and urinary catheter use. The impact of ICU-acquired infection on hospital mortality was different between drug-susceptible pathogens (HR 1.11,95% CI:0.94-1.31) and drug-resistant pathogens (HR 1.42,95% CI: 1.15-1.77).
CONCLUSIONS: The use of a ventilator or a central venous catheter, and ICU-acquired drug-resistant infection were associated with a high risk of hospital mortality in ICU patients. The potential impact on hospital mortality emphasizes the importance of preventive measures against ICU-acquired infections, especially those caused by drug-resistant pathogens.

Entities:  

Keywords:  ICU; drug resistance; hospital mortality; multicenter cohort study; nosocomial infection

Year:  2004        PMID: 21432299      PMCID: PMC2723393          DOI: 10.1007/BF02897932

Source DB:  PubMed          Journal:  Environ Health Prev Med        ISSN: 1342-078X            Impact factor:   3.674


  18 in total

Review 1.  Drug resistance in intensive care units.

Authors:  W C Albrich; M Angstwurm; L Bader; R Gärtner
Journal:  Infection       Date:  1999       Impact factor: 3.553

2.  Prevalence of infections in intensive care units in Mexico: a multicenter study.

Authors:  S P Ponce de León-Rosales; F Molinar-Ramos; G Domínguez-Cherit; M S Rangel-Frausto; V G Vázquez-Ramos
Journal:  Crit Care Med       Date:  2000-05       Impact factor: 7.598

3.  Nosocomial infection and fatality in medical and surgical intensive care unit patients.

Authors:  D E Craven; L M Kunches; D A Lichtenberg; N R Kollisch; M A Barry; T C Heeren; W R McCabe
Journal:  Arch Intern Med       Date:  1988-05

Review 4.  Impact of antibiotic resistance on clinical outcomes and the cost of care.

Authors:  M S Niederman
Journal:  Crit Care Med       Date:  2001-04       Impact factor: 7.598

5.  Interpreting hospital mortality data. The role of clinical risk adjustment.

Authors:  S F Jencks; J Daley; D Draper; N Thomas; G Lenhart; J Walker
Journal:  JAMA       Date:  1988 Dec 23-30       Impact factor: 56.272

Review 6.  Antibiotic resistance in the intensive care unit.

Authors:  M H Kollef; V J Fraser
Journal:  Ann Intern Med       Date:  2001-02-20       Impact factor: 25.391

7.  CDC definitions for nosocomial infections, 1988.

Authors:  J S Garner; W R Jarvis; T G Emori; T C Horan; J M Hughes
Journal:  Am J Infect Control       Date:  1988-06       Impact factor: 2.918

8.  Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients.

Authors:  M H Kollef; G Sherman; S Ward; V J Fraser
Journal:  Chest       Date:  1999-02       Impact factor: 9.410

9.  Organizational characteristics of intensive care units related to outcomes of abdominal aortic surgery.

Authors:  P J Pronovost; M W Jenckes; T Dorman; E Garrett; M J Breslow; B A Rosenfeld; P A Lipsett; E Bass
Journal:  JAMA       Date:  1999-04-14       Impact factor: 56.272

10.  The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee.

Authors:  J L Vincent; D J Bihari; P M Suter; H A Bruining; J White; M H Nicolas-Chanoin; M Wolff; R C Spencer; M Hemmer
Journal:  JAMA       Date:  1995 Aug 23-30       Impact factor: 56.272

View more
  3 in total

1.  Angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker use prior to medical intensive care unit admission and in-hospital mortality: propensity score-matched cohort study.

Authors:  Daiki Kobayashi; Nagato Kuriyama; Fumitaka Yanase; Osamu Takahashi; Kazuhiro Aoki; Yasuhiro Komatsu
Journal:  J Nephrol       Date:  2019-04-01       Impact factor: 3.902

2.  Incidence and outcome of sepsis in Japanese intensive care units: The Japanese nosocomial infection surveillance system.

Authors:  Machi Suka; Katsumi Yoshida; Jun Takezawa
Journal:  Environ Health Prev Med       Date:  2006-11       Impact factor: 3.674

3.  Epidemiological approach to nosocomial infection surveillance data: the Japanese Nosocomial Infection Surveillance System.

Authors:  Machi Suka; Katsumi Yoshida; Jun Takezawa
Journal:  Environ Health Prev Med       Date:  2007-12-11       Impact factor: 3.674

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.